ADPD, 16th International Conference on Alzheimer's Disease and Parkinson's Disease – 15 - 20 March 2022

AD/PD™ 2022 brings a new look and a new chapter in the history of the AD/PD™ series of conferences. By merging together with the AAT-AD/PD™ Advances in Alzheimer’s Therapies Focus Meeting, AD/PD™ is now transformed into an annual meeting, with a continuing focus on the advances in science and therapy of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.

One of Transpharmation's scientists, Caoimhe Tyndall will be presenting a poster titled 'Assessing the immunogenicity of alpha-synuclein oligomers,filaments and fibrils in a clinically relevant model of synucleinopathy in-vitro' (poster P529) at our virtual booth.InterVivo Solutions, who Transpharmation merged with in January this year, will be hosting an in-person booth at this conference in Barcelona. Whichever you decide to attend, we look forward to seeing you!

For further information on this event click here: https://adpd.kenes.com/

Now that the event is over, we have made our poster presentation available for you to view here: View Poster